Fowl Cholera (Avian Cholera) in Poultry: Etiology, Epidemiology, and Zoonotic Potential

Introduction

Fowl cholera, also known as avian cholera or avian pasteurellosis, is a highly contagious bacterial disease of domestic and wild birds caused by the Gram-negative coccobacillus Pasteurella multocida [1, 2]. The disease is recognized globally as a significant cause of morbidity and mortality in poultry flocks, particularly in chickens, turkeys, and waterfowl [3, 4]. Acute infections are characterized by septicemia with high mortality, while chronic forms present with localized inflammatory lesions [2, 5]. The term "fowl cholera" is a historical designation that distinguishes this avian disease from human cholera caused by Vibrio cholerae, though the two are etiologically unrelated. Understanding the etiology, epidemiology, and zoonotic potential of P. multocida is critical for effective disease management and biosecurity planning in commercial and backyard poultry operations [6, 7].

Etiology

The Causative Agent: Pasteurella multocida

Fowl cholera is caused by which bacteria? The answer is Pasteurella multocida, a facultative anaerobic, non-motile, Gram-negative rod that exhibits bipolar staining with Wright or Giemsa stains [1, 8]. The organism is classified under the family Pasteurellaceae and is characterized by its capsular polysaccharide and lipopolysaccharide (LPS) antigens [9, 10]. Five capsular serogroups (A, B, D, E, F) and 16 somatic LPS serotypes have been described, with serogroup A being the most prevalent in avian isolates [4, 11, 12]. The fowl cholera meaning in Bengali is "মুরগির কলেরা" (murgir kolera), reflecting the local nomenclature for this devastating poultry disease.

Genomic and Virulence Factors

The P. multocida genome encodes a diverse array of virulence factors that facilitate host colonization, immune evasion, and tissue damage [13, 11]. Key virulence determinants include the polysaccharide capsule, which inhibits phagocytosis, and LPS, which contributes to endotoxic shock [14, 15]. The hyaluronic acid capsule, encoded by the hya operon, is a critical virulence factor for serogroup A strains, and its production is negatively regulated by the stringent response [14]. The activity of the hyaD gene has been shown to contribute directly to the virulence of avian P. multocida strains [16]. Additionally, the filamentous hemagglutinin B1 (FhaB1) protein, encoded by the fhaB1 gene, has been investigated for its role in pathogenesis, though studies indicate it is not essential for virulence in turkey poults [17].

The Pasteurella multocida toxin (PMT), a potent mitogenic toxin, is a key virulence factor in some strains, particularly those associated with atrophic rhinitis in swine, though its role in avian disease is less pronounced [18]. Phase variation in glycosyltransferase genes, which modify the LPS outer core, has been linked to outbreaks of fowl cholera on free-range layer farms, suggesting that LPS structure influences host adaptation and immune evasion [10]. Genomic profiling of isolates from different geographic regions, including Bangladesh and China, has revealed significant genetic diversity and the presence of multidrug resistance genes [1, 13, 19].

Antimicrobial Resistance

Antimicrobial resistance (AMR) in avian P. multocida is a growing concern globally [13, 8, 11]. Resistance profiles vary by region and production system. Studies from Ethiopia have reported high levels of resistance to tetracyclines, sulfonamides, and penicillins among isolates from breeder chickens [8, 5]. In China, genomic characterization of avian P. multocida has identified resistance genes associated with aminoglycosides, beta-lactams, and tetracyclines [13]. Multidrug-resistant strains have also been documented in poultry and rabbits in Egypt, with resistance genes detected for multiple antimicrobial classes [11]. The emergence of AMR complicates treatment protocols and underscores the need for targeted antimicrobial stewardship and alternative control strategies [20, 21].

Epidemiology

Host Range and Transmission

Pasteurella multocida infects a wide range of avian species, including chickens, turkeys, ducks, geese, and wild waterbirds [3, 22, 12]. Turkeys are particularly susceptible to acute fowl cholera, with outbreaks often resulting in high mortality [3, 4]. Chickens, especially slow-growing broiler breeds, can experience 100% mortality in acute outbreaks [2]. Ducks are also highly susceptible, and outbreaks in duck flocks have been reported across Asia [23, 12].

Transmission occurs primarily through direct contact between infected and susceptible birds, as well as through contaminated feed, water, and fomites [6, 24]. The bacterium is shed in oral, nasal, and conjunctival secretions, as well as in feces [6]. Chronically infected carrier birds are a major reservoir for maintaining infection within flocks and introducing the pathogen to naive populations [10]. Wild birds, including waterfowl, can serve as vectors for long-distance dissemination of P. multocida strains, as demonstrated by the widespread distribution of sequence type ST20 in Australian poultry farms and wild waterbirds [22].

Environmental and Management Risk Factors

Environmental factors significantly influence the epidemiology of fowl cholera. Land cover and landscape composition have been associated with the occurrence of fowl cholera outbreaks, with certain land cover types potentially facilitating pathogen persistence or exposure [24]. High stocking density, poor ventilation, inadequate biosecurity, and concurrent infections (e.g., with Mycoplasma gallisepticum) increase the risk of clinical disease [3, 6]. A compartmental model of cholera transmission in poultry farms has highlighted the importance of rapid detection and isolation of infected birds to reduce the basic reproduction number (R0) [6].

Global Distribution

Fowl cholera is distributed worldwide, with endemic regions in Asia, Africa, Europe, and the Americas [1, 4, 22, 19]. Outbreaks are reported in both commercial and backyard flocks, with significant economic losses due to mortality, reduced egg production, and treatment costs [7]. In Bangladesh, genomic studies have characterized P. multocida type B:2 strains from fowl cholera outbreaks, revealing genetic diversity and multidrug resistance [1, 19]. In Morocco, serogroup A strains have been isolated from turkey outbreaks, and autogenous vaccines have been developed for local use [4]. In the United States, coinfection with M. gallisepticum has been associated with high mortality in commercial turkey flocks [3].

Clinical Signs

The clinical presentation of fowl cholera varies with the virulence of the strain, the host species, and the route of exposure [2, 5]. Three main forms are recognized: peracute, acute, and chronic.

Peracute and Acute Forms

Peracute fowl cholera is characterized by sudden death with few or no premonitory signs [2]. Mortality can reach 100% in susceptible flocks, particularly in slow-growing broiler chickens [2]. Acute cases present with fever, depression, anorexia, mucoid or bloody diarrhea, increased respiratory rate, and cyanosis of the comb and wattles [5]. Affected birds may exhibit lameness due to joint involvement. In laying hens, a sudden drop in egg production is a common sign [7].

Chronic Form

Chronic fowl cholera typically follows an acute outbreak or occurs in flocks with partial immunity. Localized infections manifest as swollen wattles, conjunctivitis, sinusitis, and arthritis [5]. Subcutaneous abscesses and caseous lesions in the respiratory tract are also observed. Chronic infections can persist for weeks and contribute to ongoing transmission within the flock [10].

Pathology

Gross Lesions

Postmortem examination of birds that died from acute fowl cholera reveals generalized septicemic lesions. Petechial and ecchymotic hemorrhages are commonly observed on the heart (epicardium), liver, and serosal surfaces of the abdominal organs [2, 5]. The liver is often enlarged, friable, and may exhibit multiple small, pale necrotic foci. The spleen is typically enlarged and congested. Pneumonia and airsacculitis are common in turkeys [3, 4]. In chronic cases, localized lesions include caseous arthritis, tenosynovitis, and fibrinopurulent exudate in the wattles and sinuses [5].

Histopathology

Histological examination reveals acute necrotizing hepatitis with multifocal coagulative necrosis and infiltration of heterophils [2]. Fibrinous pericarditis and epicarditis are common. In the lungs, congestion, edema, and heterophilic infiltration are observed. The presence of Gram-negative coccobacilli within macrophages and extracellularly in affected tissues is a characteristic finding [3].

Diagnostics

Bacterial Isolation and Identification

Definitive diagnosis of fowl cholera relies on the isolation and identification of P. multocida from clinical specimens [8, 5]. Samples from liver, spleen, heart blood, bone marrow, or localized lesions (e.g., swollen wattles) are collected aseptically and cultured on blood agar or MacConkey agar [8]. P. multocida appears as small, gray, non-hemolytic colonies on blood agar after 24-48 hours of incubation at 37°C. The organism is oxidase-positive, catalase-positive, and indole-positive [5]. Bipolar staining with methylene blue or Giemsa stain is a useful preliminary identification tool.

Molecular Diagnostics

Molecular methods offer high sensitivity and specificity for detecting P. multocida directly from clinical samples or pure cultures. Polymerase chain reaction (PCR) assays targeting the kmt1 gene (species-specific) and capsular serogroup genes are widely used for confirmation and serotyping [11, 25]. Loop-mediated isothermal amplification (LAMP) assays have been developed as rapid, field-deployable alternatives to PCR, with comparable sensitivity and specificity [25]. Comparative evaluations have demonstrated that LAMP assays are suitable for point-of-care diagnostics in resource-limited settings [25].

Serological Assays

Enzyme-linked immunosorbent assays (ELISAs) are used for serological surveillance and vaccine response monitoring. In-house indirect ELISA kits have been developed and optimized for detecting antibodies against P. multocida in chickens, providing a cost-effective tool for flock-level monitoring [26]. Subunit vaccines based on lipoprotein E (PlpE) have been evaluated using ELISA to measure antibody responses [27, 28].

Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing is essential for guiding treatment decisions and monitoring resistance trends. Disk diffusion and broth microdilution methods are commonly employed [8, 5]. Genomic approaches, including whole-genome sequencing, enable the detection of resistance genes and provide insights into the molecular epidemiology of resistant strains [13, 11].

Treatment

Antimicrobial Therapy

Treatment of fowl cholera is based on the administration of antimicrobial agents effective against P. multocida. Commonly used drugs include tetracyclines (e.g., oxytetracycline), sulfonamides, penicillins, and fluoroquinolones [8, 5]. However, the emergence of multidrug-resistant strains has reduced the efficacy of these agents in many regions [13, 11]. Antimicrobial susceptibility testing is strongly recommended to select appropriate therapy. Treatment is most effective when initiated early in the course of disease, and administration via drinking water or feed is typical for flock-level medication [5].

Alternative and Adjunctive Therapies

Alternative strategies to reduce antimicrobial use include the application of probiotics and plant extracts. Multi-strain probiotics have been shown to reduce fowl cholera mortality in broilers, likely through competitive exclusion and immune modulation [21]. Wild Egyptian artichoke extract has demonstrated in vitro antibacterial activity against P. multocida, suggesting potential as a natural therapeutic adjunct [20]. These approaches require further validation under field conditions.

Control and Prevention

Biosecurity

Strict biosecurity measures are the cornerstone of fowl cholera prevention. These include all-in-all-out production systems, disinfection of facilities and equipment, control of rodent and wild bird access, and quarantine of newly introduced birds [6, 7]. Prompt removal and disposal of dead birds reduce environmental contamination and transmission [6].

Vaccination

Vaccination is a key component of fowl cholera control programs. Both inactivated (bacterin) and live attenuated vaccines are available [23, 29, 30]. Inactivated vaccines are typically administered parenterally and require adjuvants to enhance immunogenicity. Gel 01 hydrogel-adjuvanted inactivated vaccines have shown protective efficacy in chickens [29]. Gamma-irradiated vaccines, formulated with various adjuvants, have induced robust antibody responses and cytokine expression in chickens [30]. Mucosal delivery of gamma-irradiated vaccines has also been explored as a safe and effective immunization strategy [31].

Live attenuated vaccines, such as the serially passaged strain PMZ8, have demonstrated attenuation and vaccine potential in ducks [23]. Autogenous vaccines, prepared from locally circulating strains, are used in some regions to address antigenic diversity [4]. Subunit vaccines targeting immunogenic proteins like PlpE, combined with flagellin as an adjuvant, have shown enhanced immunogenicity [27, 28]. The selection of an appropriate vaccine depends on the serogroup, host species, and production system.

Probiotics and Immune Modulation

Probiotic supplementation has emerged as a non-antibiotic strategy to enhance disease resistance. Multi-strain probiotics have been shown to reduce mortality in broilers experimentally challenged with P. multocida [21]. The mechanisms involve modulation of the gut microbiota, enhancement of mucosal immunity, and competitive exclusion of pathogens.

Zoonotic Potential

Avian Cholera Transmission to Humans

Avian cholera transmission to humans is a rare but documented event. Pasteurella multocida is a zoonotic pathogen that can cause localized wound infections, cellulitis, and, in immunocompromised individuals, systemic bacteremia [32]. Transmission typically occurs through bites, scratches, or close contact with infected birds or their secretions [32]. A case report documented P. multocida bacteremia in a patient following a scratch from an adopted Pekin duck, illustrating the potential for zoonotic transmission from poultry [32].

Risk Factors and Public Health Implications

Individuals with occupational exposure to poultry, including farmers, slaughterhouse workers, and veterinarians, are at increased risk of P. multocida infection [32]. Immunocompromised individuals, the elderly, and those with underlying medical conditions are more susceptible to severe disease. Although avian cholera transmission to humans is uncommon, it underscores the importance of biosecurity and personal protective equipment (PPE) when handling sick or dead birds. Public health education regarding the zoonotic potential of P. multocida is warranted, particularly in regions with high poultry density and limited biosecurity infrastructure.

Diagnostic Workflow

The following Mermaid diagram illustrates a diagnostic workflow for fowl cholera in poultry.

flowchart TD
    A[Clinical suspicion: sudden death, septicemia, swollen wattles], > B[Postmortem examination]
    B, > C[Collect samples: liver, spleen, heart blood, bone marrow, exudate]
    C, > D[Gram stain: bipolar Gram-negative coccobacilli]
    C, > E[Culture on blood agar and MacConkey agar]
    E, > F[Colony morphology: small, gray, non-hemolytic]
    F, > G[Biochemical confirmation: oxidase+, catalase+, indole+]
    G, > H[PCR: kmt1 gene for species confirmation]
    H, > I[Capsular serotyping: PCR for serogroup A, B, D, E, F]
    I, > J[Antimicrobial susceptibility testing: disk diffusion or broth microdilution]
    J, > K[Reporting and treatment guidance]
    H, > L[Optional: whole-genome sequencing for AMR and phylogenetic analysis]
    L, > K

Conclusion

Fowl cholera remains a significant threat to poultry health and productivity worldwide. The causative agent, Pasteurella multocida, exhibits considerable genetic and antigenic diversity, which complicates diagnosis and control. Antimicrobial resistance is an emerging challenge that necessitates prudent antimicrobial use and the development of alternative strategies, including vaccination and probiotics. The zoonotic potential of P. multocida, though low, warrants attention in occupational health settings. Integrated control programs combining biosecurity, vaccination, and surveillance are essential for reducing the burden of fowl cholera in poultry populations.

References

[1] Islam MA, Haque ME, Iftehimul M, et al. Genomic profiling of Pasteurella multocida strains isolated from ISA Brown (Gallus gallus domesticus) in Bangladesh. Microbiol Resour Announc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920836/

[2] Miller I, Jerry C, Nguyen V, et al. 100% Mortality in Commercial Slow-Growing Broiler Chickens with Acute Fowl Cholera. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643942/

[3] Gornatti-Churria CD, Jerry C, Ramsubeik S, et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40996859/

[4] Semmate N, Bamouh Z, Elkarhat Z, et al. Isolation and Characterization of Pasteurella multocida A from an Outbreak in Turkeys in Morocco and Vaccine Preparation and Evaluation. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643939/

[5] Geda AM. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Vet Med Int. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39669206/

[6] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. Br Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40960429/

[7] Fasina YO, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) - Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38417326/

[8] Geda AM, Wendimu A, Lulie S, et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. Int J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40297765/

[9] Hashish A, Johnson TJ, Ghanem M, et al. Complete genome sequences of eight Pasteurella multocida isolates representing all lipopolysaccharide outer core loci. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39365089/

[10] Omaleki L, Blackall PJ, Cuddihy T, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35266868/

[11] El-Tarabili RM, Enany ME, Alenzi AM, et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39948418/

[12] Xiao J, Li Y, Hu Z, et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34534643/

[13] Miao F, Dai B, Li Z, et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637789/

[14] Smallman TR, Williams GC, Harper M, et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35404102/

[15] Zhao X, Yang F, Shen H, et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35236414/

[16] Gao P, Wang L, Wang S, et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38960217/

[17] Dassanayake RP, Briggs RE, Kaplan BS, et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40140814/

[18] Kubatzky KF. Pasteurella multocida toxin - lessons learned from a mitogenic toxin. Front Immunol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36591313/

[19] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34840474/

[20] Wahdan A, Elsebai MF, Elhaig MM, et al. Innovative use of wild Egyptian artichoke extract to control fowl cholera in vitro. Vet World. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40182829/

[21] Reuben RC, Sarkar SL, Ibnat H, et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Sci Rep. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33903662/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[22] Allen JL, Bushell RN, Noormohammadi AH, et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38228079/

[23] Ji X, Meng Y, Yang H, et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747463/

[24] Ouyang L, Campler MR, Wong S, et al. Exploring the Impact of Land Cover on the Occurrence of Ornithobacteriosis and Fowl Cholera: A Case-Case Study. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39943166/

[25] Poussard M, Pant SD, Huang J, et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39448061/

[26] Beyene D, Shite A, Getachew B. Development and optimization of in-house made indirect ELISA kit for the detection of antibodies against Pasteurella multocida in chicken. BMC Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724974/

[27] Chung YC, Cheng LT, Chu CY, et al. Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine. Avian Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39400212/

[28] Cheng LT, Chu CY, Vu-Khac H, et al. Signal sequence contributes to the immunogenicity of Pasteurella multocida lipoprotein E. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36423524/

[29] Chen J, Sun Y, Hu Y, et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40934985/

[30] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40103817/

[31] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Front Immunol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34917086/

[32] Bathobakae L, Cho H, Philip S, et al. Friend Turned Foe: Pasteurella multocida Bacteremia Following a Scratch by an Adopted Pekin Duck. J Investig Med High Impact Case Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40110910/

[33] Ghadimipour R, Ghorbanpoor M, Gharibi D, et al. Effects of Selected Adjuvants on Immunogenicity and Protectivity of Pasteurella multocida Bacterin Vaccine in Chickens. Arch Razi Inst. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35096310/

[34] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34554268/

[35] Kannaki TR, Priyanka E, Haunshi S. Research Note: Disease tolerance/resistance and host immune response to experimental infection with Pasteurella multocida A:1 isolate in Indian native Nicobari chicken breed. Poult Sci. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34217907/